(Q53166363)
Statements
Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer. (English)
1 reference
N Hanna
1 reference
P Ohana
1 reference
F M Konikoff
1 reference
G Leichtmann
1 reference
A Hubert
1 reference
L Appelbaum
1 reference
Y Kopelman
1 reference
A Czerniak
1 reference
A Hochberg
1 reference
13 April 2012
1 reference
19
1 reference
6
1 reference
374-381
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference